The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of the combination of tisleizumab with chemoradiotherapy in oligorecurrence esophageal squamous cell carcinoma: A prospective phase II study.
 
Ziyu Zheng
No Relationships to Disclose
 
Xiaomin Wang
No Relationships to Disclose
 
Xinqiang Liu
No Relationships to Disclose
 
Yidian Zhao
No Relationships to Disclose
 
Nuo Yu
No Relationships to Disclose
 
Jiao Li
No Relationships to Disclose
 
Guojie Feng
No Relationships to Disclose
 
Jianjun Qin
No Relationships to Disclose
 
Xiaozheng Kang
No Relationships to Disclose
 
Yong Li
No Relationships to Disclose
 
Zhen Wang
No Relationships to Disclose
 
Xiankai Chen
No Relationships to Disclose
 
Ruixiang Zhang
No Relationships to Disclose
 
Qingfeng Zheng
No Relationships to Disclose
 
Nan Bi
No Relationships to Disclose
 
Yin Li
No Relationships to Disclose
 
Xin Wang
No Relationships to Disclose